Clinical efficacy and drug safety of rivaroxaban in the prevention and treatment of senile thromboembolic diseases

Lv Hongwei; Ren Li; Guo Daoli

doi:doi.org/10.36721/PJPS.2020.33.1.SP.409-415.1

original articles

Clinical efficacy and drug safety of rivaroxaban in the prevention and treatment of senile thromboembolic diseases

Lv Hongwei, Ren Li, Guo Daoli

Vol. 33

Issue 1

Pages 409-415

Online Date: 30 Jan 2020

Published: 30 Jan 2020

DOI: doi.org/10.36721/PJPS.2020.33.1.SP.409-415.1

Authors Abstract Related

Authors & Affiliations

Lv Hongwei

Ren Li

Guo Daoli

Abstract

As a new oral anticoagulant, rivaroxaban is equivalent to warfarin in preventing and treating thromboembolism

Keywords

Rivaroxaban

venous thrombosis

thrombotic disease

treatment and prevention

Metrics

PlumX Metrics

original articles

Clinical efficacy and drug safety of rivaroxaban in the prevention and treatment of senile thromboembolic diseases

Lv Hongwei, Ren Li, Guo Daoli

Vol. 33

Issue 1

Pages 409-415

Online Date: 30 Jan 2020

Published: 30 Jan 2020

DOI: doi.org/10.36721/PJPS.2020.33.1.SP.409-415.1

Authors Abstract Related

Authors & Affiliations

Lv Hongwei

Ren Li

Guo Daoli

Abstract

As a new oral anticoagulant, rivaroxaban is equivalent to warfarin in preventing and treating thromboembolism

Keywords

Rivaroxaban

venous thrombosis

thrombotic disease

treatment and prevention

Metrics

PlumX Metrics

Clinical efficacy and drug safety of rivaroxaban in the prevention and treatment of senile thromboembolic diseases

Authors & Affiliations

Abstract

Keywords

Metrics

Indexed & Abstracted in Leading Databases

Clinical efficacy and drug safety of rivaroxaban in the prevention and treatment of senile thromboembolic diseases

Authors & Affiliations

Abstract

Keywords

Metrics